MD Pediatrix Medical Group, Inc.
NYSE · SEC CIK 893949 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.83M 4 sales by 4 insiders
- Filings on record
- 131 since 2021-07-02, latest 2026-09-14 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Weis Shirley A | Dir | — | $855.7K |
| ORDAN MARK S | CEO, Dir | — | $515.4K |
| Rucker Michael A. | Dir | — | $241.0K |
| Linynsky Laura A | Dir | — | $216.5K |
| Neeb Don Gregory | EVP, Chief Invest, Strategy | — | — |
| Newman Kurt Douglas | Dir | — | — |
| Rossi Kasandra H | EVP, CFO, Treas | — | — |
| Young Sylvia Jean | Dir | — | — |
| Moore Mary Ann E | EVP, GC, Chief Admin Off, Sec | — | — |
| McEachin Thomas | Dir | — | — |
Transactions 153
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-15 | 2023-05-15 | MD | Pickert Curtis | EVP, COO | G - Gift | $0.00 | -5,984 | 76.6K | -7% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | Starcher John M. Jr. | Dir | A - Grant | $0.00 | +11.0K | 36.3K | +43% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | Weis Shirley A | Dir | A - Grant | $0.00 | +11.0K | 36.7K | +43% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | Linynsky Laura A | Dir | A - Grant | $0.00 | +11.0K | 19.4K | +129% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | ORDAN MARK S | Dir | A - Grant | $0.00 | +9,463 | 180.9K | +6% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | McEachin Thomas | Dir | A - Grant | $0.00 | +11.0K | 36.3K | +43% | $0 | |
| 2023-05-15 | 2023-05-11 | MD | Rucker Michael A. | Dir | A - Grant | $0.00 | +11.0K | 39.8K | +38% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Moore Mary Ann E | EVP, GC, Sec | F - Tax | $15.74 | -2,345 | 82.4K | -3% | -$36.9K | |
| 2023-03-03 | 2023-03-01 | MD | Moore Mary Ann E | EVP, GC, Sec | A - Grant | $0.00 | +55.7K | 84.7K | +192% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Pickert Curtis | EVP, COO | A - Grant | $0.00 | +55.7K | 84.9K | +190% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Pickert Curtis | EVP, COO | F - Tax | $15.74 | -2,300 | 82.6K | -3% | -$36.2K | |
| 2023-03-03 | 2023-03-01 | MD | Wood Lee | EVP, Natl, Market Ops | F - Tax | $15.74 | -2,044 | 72.2K | -3% | -$32.2K | |
| 2023-03-03 | 2023-03-01 | MD | Wood Lee | EVP, Natl, Market Ops | A - Grant | $0.00 | +39.8K | 74.2K | +116% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Richards C Marc | EVP, CFO | F - Tax | $15.74 | -9,991 | 151.0K | -6% | -$157.3K | |
| 2023-03-03 | 2023-03-01 | MD | Richards C Marc | EVP, CFO | A - Grant | $0.00 | +45.3K | 161.0K | +39% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Swift James D | CEO | A - Grant | $0.00 | +49.8K | 119.7K | +71% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Swift James D | CEO | F - Tax | $15.74 | -9,909 | 109.8K | -8% | -$156.0K | |
| 2023-01-04 | 2022-12-31 | MD | ORDAN MARK S | CEO, Dir | F - Tax | $14.86 | -98.9K | 247.7K | -29% | -$1.47M | |
| 2022-11-23 | 2022-11-21 | MD | ORDAN MARK S | CEO, Dir | S - Sale | $15.45 | -22.2K | 346.6K | -6% | -$342.5K | |
| 2022-11-09 | 2022-11-07 | MD | Swift James D | EVP, COO | S - Sale | $15.31 | -24.0K | 88.0K | -21% | -$367.4K | |
| 2022-09-28 | 2022-09-26 | MD | Andreano Dominic J | EVP, GC, Secy | F - Tax | $16.81 | -4,267 | 189.4K | -2% | -$71.7K | |
| 2022-05-13 | 2022-05-12 | MD | Weis Shirley A | Dir | A - Grant | $0.00 | +8,480 | 25.7K | +49% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | SANSONE GUY P | Dir | A - Grant | $0.00 | +8,480 | 39.0K | +28% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | McEachin Thomas | Dir | A - Grant | $0.00 | +8,480 | 25.3K | +50% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | Starcher John M. Jr. | Dir | A - Grant | $0.00 | +8,480 | 25.3K | +50% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | Rucker Michael A. | Dir | A - Grant | $0.00 | +8,480 | 28.8K | +42% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | MEDEL ROGER MD | Dir | A - Grant | $0.00 | +8,480 | 747.9K | +1% | $0 | |
| 2022-05-13 | 2022-05-12 | MD | Linynsky Laura A | Dir | A - Grant | $0.00 | -8,480 | 8,480 | -50% | $0 | |
| 2022-03-03 | 2022-03-01 | MD | Hinson Roger Mack | Pres, PDX, OBX Medical Group | F - Tax | $23.47 | -10.2K | 109.5K | -9% | -$240.4K | |
| M | 2022-03-03 | 2022-03-01 | MD | Moore Mary Ann E | EVP Chief ERM, Legal Ops Off | A - Grant | $0.00 | +32.7K | 46.9K | +230% | $0 |
| 2022-03-03 | 2022-03-01 | MD | Moore Mary Ann E | EVP Chief ERM, Legal Ops Off | F - Tax | $23.47 | -1,525 | 45.4K | -3% | -$35.8K | |
| M | 2022-03-03 | 2022-03-01 | MD | ORDAN MARK S | CEO, Dir | A - Grant | $0.00 | +152.5K | 313.2K | +95% | $0 |
| 2022-03-03 | 2022-03-01 | MD | ORDAN MARK S | CEO, Dir | F - Tax | $23.47 | -20.7K | 368.8K | -5% | -$485.6K | |
| M | 2022-03-03 | 2022-03-01 | MD | Richards C Marc | EVP, CFO | A - Grant | $0.00 | +61.0K | 153.1K | +66% | $0 |
| 2022-03-03 | 2022-03-01 | MD | Richards C Marc | EVP, CFO | F - Tax | $23.47 | -6,874 | 146.2K | -4% | -$161.3K | |
| M | 2022-03-03 | 2022-03-01 | MD | Andreano Dominic J | EVP, GC, Secy | A - Grant | $0.00 | +58.8K | 170.9K | +52% | $0 |
| 2022-03-03 | 2022-03-01 | MD | Andreano Dominic J | EVP, GC, Secy | F - Tax | $23.47 | -6,635 | 193.7K | -3% | -$155.7K | |
| M | 2022-01-11 | 2022-01-10+ | MD | MEDEL ROGER MD | Dir | S - Sale | $26.50 | -100.0K | 779.6K | -11% | -$2.65M |
| 2022-01-07 | 2022-01-05 | MD | MEDEL ROGER MD | Dir | S - Sale | $27.42 | -12.6K | 839.5K | -1% | -$346.6K | |
| M | 2022-01-04 | 2021-12-31+ | MD | MEDEL ROGER MD | Dir | S - Sale | $27.41 | -93.9K | 852.1K | -10% | -$2.57M |
| 2021-12-30 | 2021-12-30 | MD | MEDEL ROGER MD | Dir | S - Sale | $27.19 | -45.4K | 946.0K | -5% | -$1.23M | |
| M | 2021-12-29 | 2021-12-27+ | MD | MEDEL ROGER MD | Dir | S - Sale | $27.23 | -136.4K | 1.02M | -12% | -$3.71M |
| 2021-11-10 | 2021-11-10 | MD | Hinson Roger Mack | Pres, PDX, OBX Medical Group | S - Sale | $28.38 | -8,800 | 107.4K | -8% | -$249.7K | |
| 2021-11-10 | 2021-11-10 | MD | Pepia John C | Principal Accounting Off | S - Sale | $28.45 | -5,000 | 96.7K | -5% | -$142.2K | |
| 2021-10-29 | 2021-10-29 | MD | Pepia John C | Principal Accounting Off | S - Sale | $26.87 | -9,238 | 101.7K | -8% | -$248.2K | |
| 2021-10-29 | 2021-10-28 | MD | MEDEL ROGER MD | Dir | S - Sale | $29.00 | -10.4K | 1.13M | -0.9% | -$301.2K | |
| 2021-10-06 | 2021-10-04 | MD | MEDEL ROGER MD | Dir | S - Sale | $29.00 | -1,270 | 1.14M | -0.1% | -$36.8K | |
| 2021-09-03 | 2021-09-02 | MD | Pepia John C | Principal Accounting Off | S - Sale | $31.83 | -10.0K | 110.8K | -8% | -$318.3K | |
| D | 2021-08-31 | 2021-08-30 | MD | ORDAN MARK S | CEO, Dir | M - OptEx | $17.65 | +95.0K | 303.4K | +46% | +$1.68M |
| D | 2021-08-31 | 2021-08-30 | MD | ORDAN MARK S | CEO, Dir | S - Sale+OE | $35.09 | -95.0K | 208.4K | -31% | -$3.33M |
| 2021-08-11 | 2021-08-10 | MD | Hinson Roger Mack | Pres, PDX, OBX Medical Group | S - Sale | $32.35 | -8,799 | 116.1K | -7% | -$284.6K | |
| 2021-07-13 | 2021-07-12 | MD | MEDEL ROGER MD | Dir | F - Tax | $29.77 | -83.1K | 1.14M | -7% | -$2.47M | |
| 2021-07-02 | 2021-07-01 | MD | MEDEL ROGER MD | Dir | S - Sale | $30.31 | -100.0K | 1.22M | -8% | -$3.03M |
Purchase Sale Sale after option exercise All abbreviations